Overall, germline pathogenic variants were common, identified in approximately 1 in 7 tested patients.
Steven Monda, MD
Advertisement
Monda is a clinical instructor at the University of Michigan in Ann Arbor.
Articles by Steven Monda, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
2
Perioperative EV plus pembrolizumab extends survival in cisplatin-eligible MIBC
3
FDA approves rucaparib for chemotherapy-naïve, BRCA-mutated mCRPC
4
FDA grants 510(k) clearance to enhanced Revi System for urgency urinary incontinence
5